Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Access Alternative Group is a Bahamas-based boutique venture investment and advisory firm rather than a biotechnology, pharmaceutical, or healthcare operating company. Public references describe the business as providing capital formation, venture investment, and strategic advisory services across multiple sectors, including occasional involvement with biotech-related transactions through its principals. The company appears to operate under the legal name Access Alternative Group S.A. and is commonly abbreviated as AAG. Available evidence indicates it is an active private company, but there is no evidence that it develops therapeutic products, runs a drug pipeline, or operates as a life sciences platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Access Alternative Group.